Psychedelic medicine Related News
Cannabis and psychedelics: gatherings to accelerate plant-based medicine
The world's leading cannabis and psychedelic medicines scientists and researchers, investors, industry leaders and opinion makers will gather in Tel Aviv next month for...
MDMA-assisted psychotherapy for PTSD approved by FDA
A new programme will enrol 50 PTSD patients for MDMA-assisted psychotherapy following FDA approval.
The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) was recently granted...
Why MDMA must be reclassified as a Schedule 2 drug
Amanda Feilding of the Beckley Foundation discusses the organisations new report ‘Roadmaps to Regulation: MDMA’ which recommends rescheduling MDMA to a Schedule 2 drug.
MDMA...
World’s first magic mushroom nasal spray for PTSD and depression
PTSD and depression are two conditions that are being trialled for treatment with psilocybin.
A ‘magic mushroom’ nasal spray has been designed to make microdosing...
Clinical trials will look at using psilocybin to treat depression
A new wave of scientific research into psilocybin has opened up new avenues for treating depression.
King’s College London's Psychedelic Trials Group at the Centre...
Scientists undertake anorexia psilocybin treatment study
A new wave of scientific research looking at psilocybin could offer promise for the treatment of a number of mental and medical conditions –...
